Skandinaviska Enskilda Banken AB (publ) - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$506,000
+0.2%
4,2750.0%0.00%0.0%
Q4 2020$505,000
-96.1%
4,275
-96.5%
0.00%
-95.6%
Q1 2020$13,094,000
+332.3%
121,319
+204.1%
0.07%
+151.9%
Q4 2018$3,029,000
-6.3%
39,900
-1.2%
0.03%
+8.0%
Q3 2018$3,232,00040,4000.02%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q2 2020.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders